Oncology Practice Management

Featured Articles

Do No Financial Harm: How to Improve Cost Transparency in Cancer Care

We’ve heard the figures before: the price of cancer drugs has risen by orders of magnitude per month over the past decades. In addition to cancer treatment becoming more expensive, insurance design and drug formularies have changed, resulting in a greater financial burden for patients.

Read Article
One Oncologist’s Firsthand Experience with Serious Illness: What Your Patients Want

There’s really only one way to identify how patients are coping with serious illness: by asking them, according to Thomas J. Smith, MD, FACP, Director of Palliative Medicine, Johns Hopkins Medical Institutions, Baltimore, MD.

Read Article
Harnessing the Power of Data Collection and Coordination in Oncology Practice

Business intelligence is the process of collecting data from disparate systems—internal and external—and turning it into information that is meaningful and actionable toward achieving strategic goals.

Read Article
What Does an Ideal Navigation Program Look Like?

Katherine Sharpe, SVP ACS explains how to evaluate what makes an ideal navigation program.

Read Article

Top Trending Articles

1.

Empathy and an Open Mind: Design Thinking in Healthcare

By Jason Lockard, CMOM; Bettinna Signori, CMOM-HEM/ONC

Practice Management

2.

Oncology Guide to Patient Support Services Index

3.

E/M Guideline Changes and Legislative Updates: What Practices Need to Know

By Shawntea (Taya) Moheiser, CMOM, CMPE

Practice Management

In The News

Jelmyto First FDA-Approved Therapy for Low-Grade Upper-Tract Urothelial Cancer

CMS Expands Access to Telehealth Benefits During COVID-19 Outbreak

FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib

By Yvette Florio Lane

View More Articles

Highlights From the Latest Issue: May 2021, Vol 11, No 5

May 2021, Vol 11, No 5

Belzutifan: A New Approach to Treating Advanced Clear-Cell Renal-Cell Carcinoma

By Patricia Stewart

Nivolumab Improves Survival in Patients with Relapsed Malignant Mesothelioma

By William Ackerman

Addressing Lung Cancer Screening Disparities in LGBT Populations

By William Ackerman

Genomic Analysis Identifies EGFR as the Most Common Mutation in Women with Lung Cancer and No Smoking History

By William Ackerman

Practice Management

E/M Guideline Changes and Legislative Updates: What Practices Need to Know

By Shawntea (Taya) Moheiser, CMOM, CMPE

Using the 5 Whys Method to Identify and Solve Problems

By Jason Lockard, CMOM; Bettinna Signori, CMOM-HEM/ONC

Empathy and an Open Mind: Design Thinking in Healthcare

By Jason Lockard, CMOM; Bettinna Signori, CMOM-HEM/ONC

Spotlight on Epic Care: Empowerment and Excellence Through Education

By Deborah McNeilance, MBA-HCA, CMOM-HEM/ONC, CMIS, CPC, CMC

View More Articles

Reimbursement

Dispelling Misconceptions About HCC Coding

By Karyn M. Dyehouse, MD

Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding

By Kristin A. Esposito, CPhT

Medications Used for the Treatment of Lung Cancer and Associated ICD-10 Coding

By Kristin A. Esposito, CPhT

How Your Oncology Practice Can Thrive with MACRA: Get Ready for the Quality Payment Program

By Meg Barbor, MPH

View More Articles

Immunotherapy News

Therapeutic Cancer Vaccines: The Next Frontier

By Cecile Miller, MSN, CRNP; Faith A. Mutale, MSN, CRNP

Adding 2 Immunotherapies to Cabozantinib Extends Survival in Advanced Liver Cancer

By Wayne Kuznar

Atezolizumab-Bevacizumab Combo Improves Survival and Quality of Life in Unresectable Liver Cancer

By Wayne Kuznar

View More Articles

Reader Poll

New Videos

Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

By Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Interview with the Innovators

Distinctions and Parallels Among TRK Inhibitors

Distinctions and Parallels Among TRK Inhibitors

By Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Interview with the Innovators

NTRK Gene Fusion Enrichment in Patient Subpopulations

NTRK Gene Fusion Enrichment in Patient Subpopulations

By Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Interview with the Innovators

View More Videos

From the Editor

From the Editor

Will Amazon Care Disrupt Oncology Care?

By Dawn Holcombe, MBA, FACMPE, ACHE

Rumors about the entry of Amazon into the healthcare arena have been circulating for years. Now, it has become a reality in all 50 states. Although there is no guarantee that this venture will be successful, it is likely to become a seismic event for all healthcare providers and patients. Therefore, it is important to acknowledge and address its potential impact sooner rather than later. Read Article

Quick Quiz: Kidney Cancer

Quick Quiz: Kidney Cancer

Kidney cancer is among the 10 most frequently diagnosed cancers in men and women. How much do you know about kidney cancer?

Quick Quiz: Kidney Cancer

Quick Quiz: Kidney Cancer

Kidney cancer is among the 10 most frequently diagnosed cancers in men and women. How much do you know about kidney cancer?

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to recieve the free OPM print publications or weekly e‑Newsletter.

I'd like to recieve:

OPM Print Edition

OPM Weekly e‑Newsletter

I have reviewed and consent to the terms of OPM's Privacy Policy, and OPM has my permission to retain my information in its database, and to forward pertinent communications to me.